We are live on ! Find out more
DB

Danske Bank Portfolio holdings

AUM $50.6B
1-Year Est. Return 42.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+42.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33.4B
AUM Growth
+$3.43B
Cap. Flow
+$2.59B
Cap. Flow %
7.73%
Top 10 Hldgs %
37.1%
Holding
1,701
New
87
Increased
663
Reduced
541
Closed
281

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$546M
2
AMZN icon
Amazon
AMZN
+$205M
3
MSFT icon
Microsoft
MSFT
+$194M
4
NVDA icon
NVIDIA
NVDA
+$144M
5
WFC icon
Wells Fargo
WFC
+$81.7M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$44.9M
2
INTU icon
Intuit
INTU
+$34.7M
3
TMO icon
Thermo Fisher Scientific
TMO
+$28.5M
4
AMGN icon
Amgen
AMGN
+$28.3M
5
CL icon
Colgate-Palmolive
CL
+$27.5M

Sector Composition

Rank Sector Weight
1 Technology 35.41%
2 Financials 13.29%
3 Consumer Discretionary 11.92%
4 Healthcare 10.35%
5 Communication Services 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1376
Celularity
CELU
$39.9M
$2 ﹤0.01%
1
– –
CIG.C icon
1377
CEMIG Ordinary Shares
CIG.C
$9.47B
$2 ﹤0.01%
1
– –
CRVO icon
1378
CervoMed
CRVO
$38.4M
$2 ﹤0.01%
1
– –
DSS icon
1379
DSS Inc
DSS
$7.11M
$2 ﹤0.01%
2
– –
EDSA icon
1380
Edesa Biotech
EDSA
$38.7M
$2 ﹤0.01%
1
– –
ELVA
1381
Electrovaya
ELVA
$314M
$2 ﹤0.01%
1
– –
ITRG
1382
Integra Resources
ITRG
$558M
$2 ﹤0.01%
+2
New +$2
LU icon
1383
Lufax Holding
LU
$1.07B
$2 ﹤0.01%
1
– –
IMDX
1384
Insight Molecular Diagnostics
IMDX
$128M
$2 ﹤0.01%
1
– –
TOVX icon
1385
Theriva Biologics
TOVX
$10.1M
$2 ﹤0.01%
1
– –
NXTT icon
1386
Next Technology
NXTT
$8.35M
– –
0
– –
BPTH
1387
DELISTED
Bio-Path Holdings Inc
BPTH
$2 ﹤0.01%
2
– –
ADAP
1388
DELISTED
Adaptimmune Therapeutics
ADAP
$1 ﹤0.01%
1
– –
AEI icon
1389
Alset
AEI
$30.5M
$1 ﹤0.01%
1
– –
AEMD icon
1390
Aethlon Medical
AEMD
$4.47M
– –
0
– –
ALLR
1391
Allarity Therapeutics
ALLR
$16.4M
$1 ﹤0.01%
1
-7
-88% -$9
BNBX
1392
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
MBAI
1393
MBody AI Ltd. Ordinary Share
MBAI
$70.2M
– –
0
– –
BGMS
1394
Bio Green Med Solution Inc
BGMS
$6.09M
– –
0
– –
ZSTK
1395
ZeroStack Corp
ZSTK
$88.7M
– –
0
– –
INDP icon
1396
Indaptus Therapeutics
INDP
$513M
– –
0
– –
LUCD icon
1397
Lucid Diagnostics
LUCD
$158M
$1 ﹤0.01%
1
– –
ORIO
1398
Orion Digital Corp
ORIO
$24.1M
$1 ﹤0.01%
1
– –
CNSY
1399
Cerenome
CNSY
$15.1M
– –
0
– –
JF
1400
J and Friends Holdings
JF
$17.4M
$1 ﹤0.01%
1
– –

Similar funds

Danske Bank's Q4 2024 Portfolio in Review

As of Q4 2024, Danske Bank held 1,701 positions worth $33.4B, up 11% from $30B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Danske Bank deployed $2.59B of net new capital in Q4 2024, opening 87 new positions and adding to 663 existing holdings. Its largest new stake was Spotify: 42,060 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Oracle, an estimated $44.9M trimmed.

  • Danske Bank's largest Q4 2024 buy was Spotify: 42,060 shares worth $18.8M.
  • Danske Bank added most to Apple in Q4 2024, an estimated $546M increase.
  • Danske Bank's biggest Q4 2024 reduction was Oracle, cutting an estimated $44.9M.
  • Danske Bank fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $12.5M.
  • Danske Bank's ten largest holdings make up 37% of its $33.4B portfolio in Q4 2024.
  • Danske Bank opened 87 new positions and closed 281 in Q4 2024.
  • Danske Bank's portfolio value rose 11% quarter-over-quarter to $33.4B.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.